Presentation is loading. Please wait.

Presentation is loading. Please wait.

Gail A. Van Norman BTS 2016;1:170-179 Time, Money, and Success: Stages in Drug Development The highest failure rates occurs in Phase II testing, which.

Published byÈve Landry Modified over 5 years ago

Similar presentations

Presentation on theme: "Gail A. Van Norman BTS 2016;1:170-179 Time, Money, and Success: Stages in Drug Development The highest failure rates occurs in Phase II testing, which."— Presentation transcript:

1 Gail A. Van Norman BTS 2016;1:170-179
Time, Money, and Success: Stages in Drug Development The highest failure rates occurs in Phase II testing, which is the first stage in which doses of drug in humans are escalated to reach levels expected to be clinically active (i.e., the first doses at which efficacy may fail and less common side effects appear). Cumulative probability of a drug reaching U.S. Food and Drug Administration approval declines with each stage. The overall probability of a drug passing all stages is approximately 11% as of 2014 (12). Gail A. Van Norman BTS 2016;1: The Author

Download ppt "Gail A. Van Norman BTS 2016;1:170-179 Time, Money, and Success: Stages in Drug Development The highest failure rates occurs in Phase II testing, which."

Similar presentations

Overview of the Keys to Successful Commercialization Gerald J. Siuta, Ph.D. President Siuta Consulting, Inc. Tucson, Arizona October 18, 2001.

Overview of the Keys to Successful Commercialization Gerald J. Siuta, Ph.D. President Siuta Consulting, Inc. Tucson, Arizona October 18, 2001.
1Coiffier B et al. Proc ASH 2010;Abstract 114.

1Coiffier B et al. Proc ASH 2010;Abstract 114.
US Pharmaceutical/Medical Device Regulatory and Product Development Overview Tom Gardner.

US Pharmaceutical/Medical Device Regulatory and Product Development Overview Tom Gardner.
Chapter 6 Section 1 Introduction. Probability of an Event The probability of an event is a number that expresses the long run likelihood that an event.

Chapter 6 Section 1 Introduction. Probability of an Event The probability of an event is a number that expresses the long run likelihood that an event.
Phase Difference = 0.00. Phase Difference = 0.05.

Phase Difference = Phase Difference = 0.05.
What is HPV? Estimated to be the most common sexually transmitted infection in the United States.

What is HPV? Estimated to be the most common sexually transmitted infection in the United States.
Oncology Pediatric Initiatives Richard Pazdur, MD Director, Division of Oncology Drug Products.

Oncology Pediatric Initiatives Richard Pazdur, MD Director, Division of Oncology Drug Products.
Stages of drug development

Stages of drug development
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.

Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.

1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA) Katie Buhai Period 3.

Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA) Katie Buhai Period 3.
Geometric Distribution In some situations, the critical quantity is the WAITING TIME (Waiting period)  number of trials before a specific outcome (success)

Geometric Distribution In some situations, the critical quantity is the WAITING TIME (Waiting period)  number of trials before a specific outcome (success)
What is Clinical Research? SEPA Skills Curriculum Cornell Note Taking SEPA Skills Curriculum Cornell Note Taking.

What is Clinical Research? SEPA Skills Curriculum Cornell Note Taking SEPA Skills Curriculum Cornell Note Taking.
1 Statistics in Drug Development Mark Rothmann, Ph. D.* Division of Biometrics I Food and Drug Administration * The views expressed here are those of the.

1 Statistics in Drug Development Mark Rothmann, Ph. D.* Division of Biometrics I Food and Drug Administration * The views expressed here are those of the.
Practical Study Management IWRS

Practical Study Management IWRS
Updated Results of a Phase I First-in-Human Study of the BCL-2 Inhibitor ABT-199 (GDC-0199) in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic.

Updated Results of a Phase I First-in-Human Study of the BCL-2 Inhibitor ABT-199 (GDC-0199) in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic.
FDA Health Psychology. FDA = Food & Drug Administration Part of Dept of Health & __________ Services.

FDA Health Psychology. FDA = Food & Drug Administration Part of Dept of Health & __________ Services.
A Phase 3 Prospective, Randomized, International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib in Patients with.

A Phase 3 Prospective, Randomized, International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib in Patients with.
Drug Regulation, Development, Names, and Information Chapter 3 Copyright (c) 2004 Elsevier Inc. All rights reserved.

Drug Regulation, Development, Names, and Information Chapter 3 Copyright (c) 2004 Elsevier Inc. All rights reserved.
Jindal Vidya Mandir1 100 % results in class X & XII100 % results in class X & XII 98% students secured I Div. in class X98% students secured I Div. in.

Jindal Vidya Mandir1 100 % results in class X & XII100 % results in class X & XII 98% students secured I Div. in class X98% students secured I Div. in.

Similar presentations

Ads by Google